Anti-Siglec-15 antibodies and uses thereof
US9447192B2 · kind B2 · utility
3Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 6, 2012 |
| Grant date | Sep 20, 2016 |
| Priority date | — |
| Expiry date | Sep 6, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This disclosure relates to anti-Siglec-15 antibodies and uses thereof, in particular in the treatment of leukaemia, such as acute myeloid leukaemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.